Publicaciones en las que colabora con María Jesús Monte Río (43)

2024

  1. Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition

    Biochemical Pharmacology, Vol. 228

2022

  1. Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers

    Cancers, Vol. 14, Núm. 14

2021

  1. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics

    Aging, Vol. 13, Núm. 19, pp. 23416-23434

  2. Novel pharmacological options in the treatment of cholangiocarcinoma: Mechanisms of resistance

    Cancers, Vol. 13, Núm. 10

2020

  1. Cellular mechanisms accounting for the refractoriness of colorectal carcinoma to pharmacological treatment

    Cancers, Vol. 12, Núm. 9, pp. 1-34

  2. Clinical relevance of the relationship between changes in gut microbiota and bile acid metabolism in patients with intrahepatic cholangiocarcinoma

    HEPATOBILIARY SURGERY AND NUTRITION

  3. Molecular bases of drug resistance in hepatocellular carcinoma

    Cancers, Vol. 12, Núm. 6, pp. 1-26

  4. Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: A machine-learning approach

    Cancers, Vol. 12, Núm. 6, pp. 1-30

2019

  1. Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy

    Hepatology, Vol. 70, Núm. 4, pp. 1246-1261

  2. Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

    British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800

2017

  1. Lactation during cholestasis: Role of ABC proteins in bile acid traffic across the mammary gland

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Bile acids in physiology, pathology and pharmacology

    Current Drug Metabolism, Vol. 17, Núm. 1, pp. 4-29

2015

  1. Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy

    British Journal of Clinical Pharmacology, Vol. 79, Núm. 2, pp. 316-329

  2. Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT)

    Journal of Controlled Release, Vol. 216, pp. 93-102

2014

  1. Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development

    Molecular Cancer Research, Vol. 12, Núm. 1, pp. 91-100

  2. Liver metabolic/oxidative stress induces hepatic and extrahepatic changes in the expression of the vitamin C transporters SVCT1 and SVCT2

    European Journal of Nutrition, Vol. 53, Núm. 2, pp. 401-412

  3. The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy

    Acta Pharmacologica Sinica, Vol. 35, Núm. 1, pp. 1-10

2013

  1. Genetic Variants Involved in Intracellular Mechanisms of Chemoresistance to Anticancer Drugs Due to Changes in the Effect on Their Molecular Targets

    eLS

2012

  1. Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta

    Molecular Pharmacology, Vol. 81, Núm. 2, pp. 273-283

  2. Genetic variants in genes involved in mechanisms of chemoresistance to anticancer drugs

    Current Cancer Drug Targets, Vol. 12, Núm. 4, pp. 402-438